These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8759059)

  • 1. Reversing endothelial dysfunction with ACE inhibitors. A new trend.
    Rajagopalan S; Harrison DG
    Circulation; 1996 Aug; 94(3):240-3. PubMed ID: 8759059
    [No Abstract]   [Full Text] [Related]  

  • 2. Endothelial dysfunction and the promise of ACE inhibitors.
    Rockett JL
    Am J Nurs; 1999 Oct; 99(10):44-9; quiz 50. PubMed ID: 10542849
    [No Abstract]   [Full Text] [Related]  

  • 3. Endothelial dysfunction, angiotensin-converting enzyme inhibitors and calcium antagonists.
    López-Jaramillo P; Casas JP
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S34-7. PubMed ID: 11986891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular risk reduction by reversing endothelial dysfunction: ARBs, ACE inhibitors, or both? Expectations from the ONTARGET Trial Programme.
    Ruilope LM; Redón J; Schmieder R
    Vasc Health Risk Manag; 2007; 3(1):1-9. PubMed ID: 17583170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endothelium--a new target for a therapeutic action of angiotensin-converting enzyme inhibitors].
    Karpov IuA
    Ter Arkh; 2004; 76(6):94-6. PubMed ID: 15332589
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiotensin converting enzyme inhibitors and endothelial dysfunction.
    Carretaro OA
    Am J Hypertens; 1995 May; 8(5 Pt 2):42S-44S. PubMed ID: 7646843
    [No Abstract]   [Full Text] [Related]  

  • 7. [Asymmetric dimethylarginine and endothelial dysfunction].
    Yoshizumi M
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():555-60. PubMed ID: 15506448
    [No Abstract]   [Full Text] [Related]  

  • 8. ACE inhibitors, diabetes and cardiovascular disease.
    Gazis A; Page SR; Cockcroft JR
    Diabetologia; 1998 May; 41(5):595-7. PubMed ID: 9628279
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study.
    Mancini GB; Henry GC; Macaya C; O'Neill BJ; Pucillo AL; Carere RG; Wargovich TJ; Mudra H; Lüscher TF; Klibaner MI; Haber HE; Uprichard AC; Pepine CJ; Pitt B
    Circulation; 1996 Aug; 94(3):258-65. PubMed ID: 8759064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE inhibitors and the arterial wall. Introduction.
    Frishman WH
    Postgrad Med; 2000 Oct; 108(5 Suppl):3. PubMed ID: 19667534
    [No Abstract]   [Full Text] [Related]  

  • 11. Improved endothelial function with angiotensin-converting enzyme inhibitors.
    Pepine CJ
    Am J Cardiol; 1997 Mar; 79(5A):29-32. PubMed ID: 9127619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vascular endothelium: target organ of cardiovascular pathologies].
    Berkenboom G
    Ann Cardiol Angeiol (Paris); 1999 Nov; 48(9-10):643-6. PubMed ID: 12555471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of endothelial dysfunction in cardiovascular diseases and methods of its correction with drugs].
    gidullin NSh; Valeeva KF; Gassanov N; Zagidullin ShZ
    Kardiologiia; 2010; 50(5):54-60. PubMed ID: 20831049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging role of ACE inhibitors in diabetes: from theory to therapeutic management.
    Yudkin JS
    J Diabetes Complications; 1996; 10(3):129-32. PubMed ID: 8807456
    [No Abstract]   [Full Text] [Related]  

  • 15. Blockade of endothelial enzymes: new therapeutic targets.
    López-Jaramillo P; Casas JP
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S100-3. PubMed ID: 11986905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of ACE inhibitors and fibrates on endothelial function].
    Januszewicz A
    Kardiol Pol; 2005 Jun; 62 Suppl 2():II60-4. PubMed ID: 19813338
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cardiovascular diseases. Improvement of the endothelial function as strategic therapeutic aim].
    Z Kardiol; 1998 Jun; 87(6 Suppl Besserung):1-4. PubMed ID: 9698652
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of angiotensin-converting enzyme inhibitors on vascular endothelial function in hypertensive patients after intensive periodontal treatment.
    Rubio MC; Lewin PG; De la Cruz G; Sarudiansky AN; Nieto M; Costa OR; Nicolosi LN
    Acta Odontol Latinoam; 2016 Apr; 29(1):60-67. PubMed ID: 27701500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endothelial dysfunction and angiotensin-converting enzyme inhibitors in coronary disease].
    Mélon P
    Rev Med Liege; 1998 Jun; 53(6):353-4. PubMed ID: 9713215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic, pharmacokinetic, and therapeutic differences among ACE inhibitors.
    White CM
    Pharmacotherapy; 1998; 18(3):588-99. PubMed ID: 9620109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.